Apellis Pharmaceuticals buy BiotechBee
Start price
17.07.23
/
60%
€50.50
Target price
31.03.26
€90.00
Performance (%)
18.81%
End price
17.07.23
€60.00
Summary
This prediction ended on 17.07.23 with a price of €60.00. The prediction had a final performance of 18.81%. BiotechBee has a follow-up prediction for Apellis Pharmaceuticals where he still thinks Apellis Pharmaceuticals is a Buy. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Apellis Pharmaceuticals | - | - |
| iShares Core DAX® | 2.594% | -1.158% |
| iShares Nasdaq 100 | 3.553% | -1.727% |
| iShares Nikkei 225® | 0.687% | -8.354% |
| iShares S&P 500 | 2.209% | -0.942% |
According to BiotechBee what are the pros and cons of Apellis Pharmaceuticals for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Apellis Pharmaceuticals diskutieren
In the thread Trading Apellis Pharmaceuticals
Current prediction by BiotechBee for Apellis Pharmaceuticals
Apellis Pharmaceuticals
Start price
Target price
Perf. (%)
€41.00
17.09.23
17.09.23
€60.00
30.09.25
30.09.25
13.60%
26.04.24
26.04.24
Could be very worthwhile Investment >20% year
Stopped prediction by BiotechBee for Apellis Pharmaceuticals
Apellis Pharmaceuticals
Start price
Target price
Perf. (%)
€37.00
30.07.23
30.07.23
€50.00
31.01.26
31.01.26
10.81%
17.09.23
17.09.23
Could be very worthwhile Investment >20% year
Apellis Pharmaceuticals
Start price
Target price
Perf. (%)
€69.48
29.09.22
29.09.22
€80.00
31.12.24
31.12.24
17.30%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Apellis Pharmaceuticals
Start price
Target price
Perf. (%)
€64.19
07.09.22
07.09.22
€35.00
31.12.24
31.12.24
8.24%
29.09.22
29.09.22
Could be very worthwhile Investment >20% year